X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7154) 7154
science & technology (5504) 5504
life sciences & biomedicine (5339) 5339
male (4898) 4898
female (3759) 3759
myocardial infarction - chemically induced (3110) 3110
middle aged (2940) 2940
aged (2447) 2447
cardiovascular system & cardiology (2224) 2224
animals (2135) 2135
abridged index medicus (2010) 2010
cardiac & cardiovascular systems (2009) 2009
myocardial infarction (1927) 1927
myocardial infarction - drug therapy (1821) 1821
risk factors (1755) 1755
adult (1690) 1690
hemorrhage - chemically induced (1373) 1373
rats (1093) 1093
treatment outcome (1039) 1039
electrocardiography (970) 970
general & internal medicine (924) 924
time factors (897) 897
heart attack (876) 876
medicine, general & internal (861) 861
heart attacks (809) 809
pharmacology & pharmacy (759) 759
myocardial infarction - prevention & control (706) 706
platelet aggregation inhibitors - adverse effects (702) 702
myocardial infarction - complications (672) 672
myocardial infarction - mortality (670) 670
cardiology (616) 616
myocardial infarction - physiopathology (615) 615
risk assessment (574) 574
drug therapy, combination (571) 571
myocardial infarction - therapy (568) 568
myocardial infarction - etiology (557) 557
platelet aggregation inhibitors - therapeutic use (547) 547
peripheral vascular disease (540) 540
myocardial infarction - diagnosis (532) 532
myocardial infarction - pathology (532) 532
myocardium - pathology (529) 529
mortality (527) 527
cardiovascular disease (524) 524
myocardial infarction - epidemiology (516) 516
cardiovascular diseases (510) 510
aged, 80 and over (503) 503
ischemia (491) 491
anticoagulants - adverse effects (466) 466
drug therapy (459) 459
care and treatment (456) 456
heart (456) 456
disease models, animal (452) 452
myocardium - metabolism (447) 447
rats, wistar (447) 447
randomized controlled trials as topic (445) 445
retrospective studies (439) 439
stroke (431) 431
cardiovascular (423) 423
isoproterenol (421) 421
prospective studies (407) 407
arrhythmias, cardiac - chemically induced (404) 404
research (398) 398
dose-response relationship, drug (397) 397
health aspects (397) 397
cardiovascular diseases - chemically induced (394) 394
fibrinolytic agents - adverse effects (394) 394
risk (391) 391
anticoagulants - therapeutic use (388) 388
follow-up studies (386) 386
incidence (384) 384
analysis (370) 370
coronary angiography (370) 370
myocardial infarction - metabolism (370) 370
platelet aggregation inhibitors - administration & dosage (365) 365
cardiac patients (355) 355
ticlopidine - analogs & derivatives (353) 353
heart - drug effects (350) 350
medicine & public health (348) 348
heart diseases (344) 344
aspirin - adverse effects (337) 337
aspirin - therapeutic use (324) 324
stroke - chemically induced (322) 322
thrombolytic therapy - adverse effects (322) 322
heparin - adverse effects (314) 314
heart failure (307) 307
myocardial ischemia - chemically induced (306) 306
double-blind method (304) 304
percutaneous coronary intervention (303) 303
stents (303) 303
fibrinolytic agents - therapeutic use (293) 293
rats, sprague-dawley (293) 293
myocardial infarction - blood (292) 292
acute disease (282) 282
adolescent (282) 282
clinical trials as topic (282) 282
diabetes (281) 281
angioplasty, balloon, coronary (272) 272
mice (268) 268
research article (267) 267
aspirin (265) 265
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8088) 8088
German (278) 278
French (156) 156
Spanish (102) 102
Italian (86) 86
Russian (84) 84
Japanese (70) 70
Polish (56) 56
Dutch (28) 28
Portuguese (26) 26
Norwegian (24) 24
Danish (23) 23
Swedish (20) 20
Chinese (17) 17
Turkish (12) 12
Hungarian (10) 10
Finnish (9) 9
Hebrew (9) 9
Czech (7) 7
Bulgarian (6) 6
Serbian (6) 6
Romanian (4) 4
Slovak (4) 4
Ukrainian (3) 3
Afrikaans (2) 2
Lithuanian (2) 2
Croatian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 2, pp. 153 - 163
Journal Article
The New England journal of medicine, ISSN 1533-4406, 06/2012, Volume 366, Issue 24, pp. 2257 - 2266
Journal Article
PloS one, ISSN 1932-6203, 2019, Volume 14, Issue 11, pp. e0225185 - e0225185
Journal Article
The New England journal of medicine, ISSN 1533-4406, 05/2015, Volume 372, Issue 19, pp. 1791 - 1800
Patients with myocardial infarction 1 to 3 years previously were assigned to ticagrelor, 90 or 60 mg twice daily, or to placebo, in addition to low-dose aspirin... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Purinergic P2Y Receptor Antagonists - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Risk | Secondary Prevention | Adenosine - administration & dosage | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Myocardial Infarction - drug therapy | Adenosine - adverse effects | Adenosine - analogs & derivatives | Intracranial Hemorrhages - chemically induced | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Aged | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Dose-response relationship (Biochemistry) | Treatment outcome | Care and treatment | Safety and security measures | Analysis | Dosage and administration | Ticagrelor | Heart attack | Risk factors | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Heart attacks | Hemorrhage | Long term | Patients | Thrombolysis | Bleeding | Blood platelets | Antagonist drugs | Cardiovascular diseases | Drug therapy | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology
Journal Article
Journal Article
by Meade, T and Collins, R and Armitage, J and Parish, S and Barton, J and Bray, C and Wincott, E and Bowman, L and Clarke, R and Graham, I and Simpson, D and Warlow, C and Tobert, J and Musliner, T and Doll, R and Fox, K.M and Hill, C and Sandercock, P and Peto, R and Webster, J and Jamieson, J and Nixon, A and Lackie, S and Thompson, J and Brown, M and Blackwood, S and Morgan, M and Rhoden, W and Saeed, B and Houghton, M and Nicholson, A and Simpson, C and Hoburn, B and Cooper, I and Gallivan, A and Pickerell, E and Hancock, J and Watkinson, J and Burbridge, W and Kitchen, M and O'Leary, H and Verow, C and Meynell, L and Rollinson, L and Bain, S and Jones, A and Jewkes, C and Russon, C and Bateson, M and Gill, P and Stansbie, D and Bayly, G and Andrews, G and Halestrap, M and Meredith, J and Best, R and Appleyard, D and Wareing, H and Holmes, K and Holt, J and Kenyon, M and White, C and Khalifa, M and Newton, D and Wass, A and Watkinson, R and Creamer, J and Bethell, A and Butler, C and Washington, M and Weston, E and Machin, J and Cleaver, K and Wray, R and Sinclair, J and Van Aalst, A and Been, M and Mattu, R and Burke, A and Gill, L and Walton, E and Cowley, M and Robson, H and Graham, A and Rose, G and Kerr, M and Mallinson, J and Peascod, B and Scott, A and Donnelly, R and Gibson, T and Hannah, J and Henshaw, L and Margetts, M and Pearson, N and Frost, S and Murray, S and Marshall, A and Went, J and Simmonds, J and ... and unav and The SEARCH Collaborative Group and SEARCH Collaborative Grp and SEARCH Collaborative Group and Sahlgrenska akademin and Institutionen för medicin, avdelningen för akut och kardiovaskulär medicin and Institute of Medicine, Department of Emergeny and Cardiovascular Medicine and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
The New England journal of medicine, ISSN 1533-4406, 08/2008, Volume 359, Issue 8, pp. 789 - 799
A genomewide association study was conducted to determine the common variants that are associated with an increased risk of statin-induced myopathy... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Simvastatin - therapeutic use | Simvastatin - adverse effects | Humans | Middle Aged | Diabetes Mellitus - drug therapy | Genotype | Male | Risk | Genetic Markers | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacokinetics | Organic Anion Transporters - genetics | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Myocardial Infarction - drug therapy | Arterial Occlusive Diseases - drug therapy | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Female | Aged | Myocardial Infarction - prevention & control | Polymorphism, Single Nucleotide | Chromosomes, Human, Pair 12 | Muscular Diseases - chemically induced | Muscular Diseases - genetics | Solute Carrier Organic Anion Transporter Family Member 1b1 | Complications and side effects | Analysis | Muscle diseases | Genetic aspects | Dosage and administration | Single nucleotide polymorphisms | Risk factors | Statins | Drug therapy | Kinases | Drug dosages | Cholesterol | Index Medicus | Abridged Index Medicus | MEDICIN OCH HÄLSOVETENSKAP | Single Nucleotide | genetics | Arterial Occlusive Diseases | pharmacokinetics | Muscular Diseases | Hydroxymethylglutaryl-CoA Reductase Inhibitors | Chromosomes | MEDICAL AND HEALTH SCIENCES | Human | drug therapy | chemically induced | Simvastatin | prevention & control | Diabetes Mellitus | Myocardial Infarction | Pair 12 | Organic Anion Transporters | adverse effects | therapeutic use | Polymorphism
Journal Article
The New England journal of medicine, ISSN 1533-4406, 04/2007, Volume 356, Issue 17, pp. 1723 - 1735
Journal Article